Remicade & reg; & nbsp;(infliximab): & nbsp;20 years of contributions to science and medicine
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - July 30, 2019 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

Clinical utility of ramucirumab in non-small-cell lung cancer
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - July 21, 2019 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

Therapeutic drug monitoring of biologics in psoriasis
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - July 5, 2019 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

Antitumor and antibacterial properties of virally encoded cationic sequences
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - June 25, 2019 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

Recurrent ruptured abdominal aneurysms in polyarteritis nodosa successfully treated with infliximab
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - June 14, 2019 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

TRIP6 functions as a potential oncogene and facilitated proliferation and metastasis of gastric cancer
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - June 11, 2019 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

Infliximab in treatment of idiopathic refractory childhood pyoderma gangrenosum (PG)
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - May 27, 2019 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

New horizons for the treatment of severe, eosinophilic asthma: benralizumab, a novel precision biologic
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - May 22, 2019 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

Outcomes of various types of therapy in patients with treatment-resistant acrodermatitis continua of Hallopeau
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - May 20, 2019 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

Dupilumab side effect in a patient with atopic dermatitis: a case report study
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - May 13, 2019 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

Systematic review of immunomodulatory therapies for hidradenitis suppurativa
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - May 13, 2019 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

Monoclonal antibody therapy of solid tumors: clinical limitations and novel strategies to enhance treatment efficacy
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - May 1, 2019 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

Has infliximab influenced the course and prognosis of acute severe ulcerative colitis?
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - April 8, 2019 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

Efficacy of adalimumab as second-line therapy in a pediatric cohort of Crohn & rsquo;s disease patients who failed infliximab therapy: the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition experience
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - January 2, 2019 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

Spotlight on dinutuximab in the treatment of high-risk neuroblastoma: development and place in therapy
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - December 21, 2018 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

The role of microfluidics in protein formulations with pre-programmed functional characteristics
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - December 3, 2018 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

Combination of EGFR-TKIs with chemotherapy versus chemotherapy or EGFR-TKIs alone in advanced NSCLC patients with EGFR mutation
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - November 30, 2018 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

Infliximab dose adjustment can improve the clinical and radiographic outcomes of rheumatoid arthritis patients: REVIVE study results
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - November 27, 2018 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

Structural and functional comparability study of anti-CD20 monoclonal antibody with reference product
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - November 23, 2018 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

Analysis of drug utilization and health care resource consumption in patients with psoriasis and psoriatic arthritis before and after treatment with biological therapies
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - November 12, 2018 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

The effects of golimumab treatment on systolic and diastolic left ventricular function in ankylosing spondylitis
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - November 8, 2018 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

Two decades with omalizumab: what we still have to learn
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - October 26, 2018 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

Analysis of real-world treatment patterns in a matched rheumatology population that continued innovator infliximab therapy or switched to biosimilar infliximab
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - October 25, 2018 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

Designing of CD8+ and CD8+-overlapped CD4+ epitope vaccine by targeting late and early proteins of human papillomavirus
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - October 2, 2018 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

A descriptive analysis of real-world treatment patterns of innovator (Remicade & reg;) and biosimilar infliximab in an infliximab-na & iuml;ve Turkish population
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - October 2, 2018 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

Focus on biosimilar etanercept & ndash; bioequivalence and interchangeability
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - August 30, 2018 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

Combined treatment with metformin and gefitinib overcomes primary resistance to EGFR-TKIs with EGFR mutation via targeting IGF-1R signaling pathway
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - August 20, 2018 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

Efficacy of ustekinumab against infliximab-induced psoriasis and arthritis associated with Crohn & rsquo;s disease
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - July 19, 2018 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

The conundrum of indeterminate QuantiFERON-TB Gold results before anti-tumor necrosis factor initiation
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - February 27, 2018 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

New frontiers in oncolytic viruses: optimizing and selecting for virus strains with improved efficacy
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - February 9, 2018 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

Correlation between HLA haplotypes and the development of antidrug antibodies in a cohort of patients with rheumatic diseases
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - January 30, 2018 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

Analytical characterization of recombinant hCG and comparative studies with reference product
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - January 30, 2018 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

Bezlotoxumab: an emerging monoclonal antibody therapy for prevention of recurrent Clostridium difficile infection
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - January 18, 2018 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

Tuberculosis and viral hepatitis infection in Eastern Europe, Asia, and Latin America: impact of tumor necrosis factor- & alpha; inhibitors in clinical practice
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - January 12, 2018 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

Anti-angiogenic effects of biotechnological therapies in rheumatic diseases
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - December 14, 2017 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

Octreotide long-acting repeatable in the treatment of neuroendocrine tumors: patient selection and perspectives
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - December 6, 2017 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

Anticholinesterase constituents from the leaves of Spondias mombin L. (Anacardiaceae)
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - August 2, 2017 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

Epigenetic memory of oxidative stress: does nephrilin exert its protective effects via Rac1?
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - July 17, 2017 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

Patient profiles and clinical utility of mepolizumab in severe eosinophilic asthma
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - June 27, 2017 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

Autophagy regulates the stemness of cervical cancer stem cells
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - June 21, 2017 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

Paradoxical SAPHO syndrome observed during anti-TNF- & alpha; therapy for Crohn & #39;s disease
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - May 22, 2017 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

Development of a potent invigorator of immune responses endowed with both preventive and therapeutic properties
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - May 2, 2017 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

CUL4A promotes cell invasion in gastric cancer by activating the NF- & kappa;B signaling pathway
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - April 12, 2017 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

New developments in the treatment of multiple myeloma & ndash; clinical utility of daratumumab
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - April 11, 2017 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

Neutralizing activities against seasonal influenza viruses in human intravenous immunoglobulin
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - March 10, 2017 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

A practical guide about biosimilar data for health care providers treating inflammatory diseases
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - February 23, 2017 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

Biosimilars and the extrapolation of indications for inflammatory conditions
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - February 17, 2017 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

Centrosome & ndash; a promising anti-cancer target
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - December 12, 2016 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

Pharmacoutilization of epoetins in na & iuml;ve patients with hematological malignancies in an unselected Italian population under clinical practice setting: a comparative analysis between originator and biosimiliars
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - December 1, 2016 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research

Update on sepsis-associated acute kidney injury: emerging targeted therapies
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - November 6, 2016 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research